Persistence and proliferation of human mesenchymal stromal cells in the right ventricular myocardium after intracoronary injection in a large animal model of pulmonary hypertension

Cytotherapy

Volumn 19, Issue 6, 2017, Pages 668-679

  Badr Eslam, Roza ^a,b   Croce, Kevin ^a   Mangione, Fernanda Marinho ^a   Musmann, Robert ^a   Leopold, Jane A ^a   Mitchell, Richard N ^a   Waxman, Aaron B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

differentiation; human mesenchymal stromal cells; intracoronary injection; pulmonary hypertension; right ventricular remodeling

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; CONNEXIN 43; DESMIN; ENDOGLIN; KI 67 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE MUSCLE; HEART TISSUE; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG ARTERY PRESSURE; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; PULMONARY VEIN BANDING; RIGHT CORONARY ARTERY; UPREGULATION; VEIN SURGERY; YORKSHIRE PIG; ANIMAL; CYTOLOGY; GENETICS; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; INTRAARTERIAL DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MORTALITY; PATHOLOGY; PIG; PLACENTA; PREGNANCY; PROCEDURES;

ANIMALS; CELL PROLIFERATION; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; IN SITU HYBRIDIZATION, FLUORESCENCE; INJECTIONS, INTRA-ARTERIAL; LEUKOCYTE COMMON ANTIGENS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIUM; PLACENTA; PREGNANCY; SWINE; VENTRICULAR FUNCTION, RIGHT;

EID: 85017191331     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2017.03.002     Document Type: Article

References (33)

1. [1] Zhu, Y., Song, X., Wang, J., Li, Y., Yang, Y., Yang, T., et al. Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition. Expert Opin Biol Ther 15:2 (2015), 163–180.
2. [2] Zhu, Y., Yang, Y., Zhang, Y., Hao, G., Liu, T., Wang, L., et al. Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther, 5(2), 2014, 48.
3. [3] Clifford, D.M., Fisher, S.A., Brunskill, S.J., Doree, C., Mathur, A., Watt, S., et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev(2), 2012 CD006536.
4. [4] Martin-Rendon, E., Snowden, J.A., Watt, S.M., Stem cell-related therapies for vascular diseases. Transfus Med 19:4 (2009), 159–171.
5. [5] Harvey, E., Fisher, S.A., Doree, C., Taggart, D.P., Martin-Rendon, E., Current evidence of the efficacy of cell-based therapies in heart failure. Circ J 79:2 (2015), 229–236.
6. [6] Ding, Z., Burghoff, S., Buchheiser, A., Kogler, G., Schrader, J., Survival, integration, and differentiation of unrestricted somatic stem cells in the heart. Cell Transplant 22:1 (2013), 15–27.
7. [7] Gyongyosi, M., Hemetsberger, R., Wolbank, S., Kaun, C., Posa, A., Marian, T., et al. Imaging the migration of therapeutically delivered cardiac stem cells. JACC Cardiovasc Imaging 3:7 (2010), 772–775.
8. [8] Noiseux, N., Marquis-Gravel, G., Mansour, S., Shahzad, U., Stewart, D.J., Yau, T.M., The current state of stem cell therapeutics: Canadian approaches in the international context. Can J Cardiol 30:11 (2014), 1361–1369.
9. [9] Fiarresga, A., Mata, M.F., Cavaco-Goncalves, S., Selas, M., Simoes, I.N., Oliveira, E., et al. Intracoronary delivery of human mesenchymal/stromal stem cells: insights from coronary microcirculation invasive assessment in a swine model. PLoS ONE, 10, 2015, e0139870.
10. [10] Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 8:3 (2011), 223–272.
11. [11] Sueblinvong, V., Loi, R., Eisenhauer, P.L., Bernstein, I.M., Suratt, B.T., Spees, J.L., et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 177:7 (2008), 701–711.
12. [12] Aguero, J., Ishikawa, K., Hadri, L., Santos-Gallego, C., Fish, K., Hammoudi, N., et al. Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. Am J Physiol Heart Circ Physiol, 307(8), 2014 H1204–15.
13. [13] Konishi, M., Erdem, S.S., Weissleder, R., Lichtman, A.H., McCarthy, J.R., Libby, P., Imaging granzyme B activity assesses immune-mediated myocarditis. Circ Res 117:6 (2015), 502–512.
14. [14] Breuckmann, F., Nassenstein, K., Bucher, C., Konietzka, I., Kaiser, G., Konorza, T., et al. Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. JACC Cardiovasc Imaging 2:2 (2009), 121–130.
15. [15] Blazquez, R., Sanchez-Margallo, F.M., Crisostomo, V., Baez, C., Maestre, J., Alvarez, V., et al. Intrapericardial delivery of cardiosphere-derived cells: an immunological study in a clinically relevant large animal model. PLoS ONE, 11, 2016 e0149001.
16. [16] Heiberg, E., Sjogren, J., Ugander, M., Carlsson, M., Engblom, H., Arheden, H., Design and validation of Segment—freely available software for cardiovascular image analysis. BMC Med Imaging, 10, 2010, 1.
17. [17] Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:4 (2006), 315–317.
18. [18] Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:4 (2005), 1815–1822.
19. [19] Passier, R., Oostwaard, D.W., Snapper, J., Kloots, J., Hassink, R.J., Kuijk, E., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23:6 (2005), 772–780.
20. [20] Muller, A.M., Hermanns, M.I., Skrzynski, C., Nesslinger, M., Muller, K.M., Kirkpatrick, C.J., Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol 72:3 (2002), 221–229.
21. [21] Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:9 (2006), 1114–1122.
22. [22] Andree, H., Nickel, P., Nasiadko, C., Hammer, M.H., Schonemann, C., Pruss, A., et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 17:2 (2006), 573–580.
23. [23] Ankrum, J.A., Ong, J.F., Karp, J.M., Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32:3 (2014), 252–260.
24. [24] Herrero, C., Pérez-Simón, J.A., Immunomodulatory effect of mesenchymal stem cells. Braz J Med Biol Res 43 (2010), 425–430.
25. [25] Li, C.D., Zhang, W.Y., Li, H.L., Jiang, X.X., Zhang, Y., Tang, P.H., et al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 15:7 (2005), 539–547.
26. [26] Wehman, B., Sharma, S., Pietris, N., Mishra, R., Siddiqui, O.T., Bigham, G., et al. Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload. Am J Physiol Heart Circ Physiol, 310(11), 2016 H1816–26.
27. [27] Keith, M.C., Tang, X.L., Tokita, Y., Li, Q.H., Ghafghazi, S., Moore Iv, J., et al. Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs. PLoS ONE, 10(4), 2015 e0124227.
28. [28] Bolli, R., Tang, X.L., Sanganalmath, S.K., Rimoldi, O., Mosna, F., Abdel-Latif, A., et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128:2 (2013), 122–131.
29. [29] Ellison, G.M., Torella, D., Dellegrottaglie, S., Perez-Martinez, C., Perez de Prado, A., Vicinanza, C., et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol 58:9 (2011), 977–986.
30. [30] Bartunek, J., Behfar, A., Vanderheyden, M., Wijns, W., Terzic, A., Mesenchymal stem cells and cardiac repair: principles and practice. J Cardiovasc Transl Res 1:2 (2008), 115–119.
31. [31] Pittenger, M.F., Martin, B.J., Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:1 (2004), 9–20.
32. [32] Amado, L.C., Saliaris, A.P., Schuleri, K.H., St John, M., Xie, J.S., Cattaneo, S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102:32 (2005), 11474–11479.
33. [33] Kraitchman, D.L., Heldman, A.W., Atalar, E., Amado, L.C., Martin, B.J., Pittenger, M.F., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:18 (2003), 2290–2293.